参考文献
[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2]Logan A.The surgical treatment of carcinoma of the esophagus and cardia[J].J Thorac Cardiovasc Surg,1963,46(2):150-163.
[3]Isono K,Sato H,Nakayama K.Results of a nationwide study on the three-field lymph node dissection of esophageal cancer[J].Oncology,1991,48(5):411-420.
[4]Fumagalli U,Akiyama H,Demeester TR.Resective surgery for cancer of the thoracic esophagus.Results of a Consensus Conference held at the VIth World Congress of the International Society for Diseases of the Esophagus[J].Dis Esophagus,1996,9:30-38.
[5]Fujita H,Kakegawa T,Yamana H,et al.Mortality and morbidity rates,postoperative course,quality of life,and prognosis after extended radical lymphadenectomy for esophageal cancer.Comparison of three-field lymphadenectomy with two-field lymphadenectomy[J].Ann Surg,1995,222(5):654-662.
[6]Fujita H,Sueyoshi S,Tanaka T,et al.Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus:comparing the short- and long-term outcome among the four types oflymphadenectomy[J].World J Surg,2003,27(5):571-579.
[7]Altorki NK,Skinner DB.Occult cervical nodal metastasis in esophageal cancer:preliminary results of three-field lymphadenectomy[J].J Thorac Cardiovasc Surg,1997,113(3):540-544.
[8]Law SY,Fok M,Wong J.Pattern of recurrence after resection for cancer:clinical implications[J].Br J Surg,1996,83(1):107-111.
[9]Tam PC,Cheung HC,Ma L,et al.Local recurrences after subtotal esophagectomy for squamous cell carcinoma[J].Ann Surg,1987,205(2):189-194.
[10]张国庆,韩峰,孙伟,等.不同淋巴结清扫范围对Ⅲ期食管癌患者术后生存的影响[J].中华肿瘤杂志,2008,30(11):858-862.
[11]柳硕岩,朱坤寿,郑庆丰,等.三野与二野淋巴结清扫对胸段食管鳞癌患者术后生存的影响[J].中华胸心血管外科杂志,2014,30(11):645-648.
[12]Shim YM,Kim HK,Kim K.Comparison of survival and recurrence pattern between twofield and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma[J].J Thorac Oncol,2010,5(5):707-712.
[13]Roder JD,Busch R,Stein HJ,et al.Ratio ofinvaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus[J].Br J Surg,1994,81(3):410-413.
[14]Noguchi T,Wada S,Takeno S,et al.Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma[J].Dis Esophagus,2004,17(1):27-31.
[15]Miyata H,Yano M,Doki Y,et al.A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers,based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes[J].J Surg Oncol,2006,93(6):477-484.
[16]Liu S,Anfossi S,Qiu B,et al.Prognostic Factors for Locoregional Recurrence in Patients with Thoracic Esophageal Squamous Cell Carcinoma Treated with Radical Two-Field Lymph Node Dissection:Results from Long-Term Follow-Up[J].Ann Surg Oncol,2017,24(4):966-973.
[17]Horstmann O,Verreet PR,Becker H,et al.Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer[J].Eur J Surg,1995,161(8):557-567.
[18]Hagen JA,Peters JH,DeMeester TR.Superiority of extended en-bloc esophagectomy for carcinoma of the lower esophagus and cardia[J].J Thor Cardiovasc Surg,1993,106(5):850-858.
[19]Gould EA,Winship T,Philbin PH,et al.Observations on a "sentinel node" in cancer of the parotid[J].Cancer,1960,13(1):77-78.
[20]Morton DL,Wen DR,Wong JH,et al.Technical details of intraoperative lymphatic mapping for early stage melanoma[J].Arch Surg,1992,127(4):392-399.
[21]Giuliano AE,Kirgan DM,Guenther JM,et al.Lymphatic mapping and sentinel lymphadenectomy for breast cancer[J].Ann Surg,1994,220(3):391-398; discussion 398-401.(https://www.daowen.com)
[22]Udagawa H.Sentinel node concept in esophageal surgery:an elegant strategy[J].Ann Thorac Cardiovasc Surg,2005,11(1):1-3.
[23]Burian M,Stein HJ,Sendler A,et al.Sentinel node detection in Barrett's and cardia cancer[J].Ann Surg Oncol,2004,11(3 Suppl):255S-258S.
[24]赵宏光,胡艳君,毛伟敏,等.食管癌右喉返神经旁淋巴结转移的相关因素研究[J].中华肿瘤杂志,2010,32(5):387-390.
[25]Noguchi H,Yano M,Tsujinaka T,et al.Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer[J].Dis Esophagus,2001,14(3-4):191-196.
[26]Ueda Y,Shiozaki A,Itoi H,et al.Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer[J].Oncol Rep,2006,16(5):1061-1066.
[27]Li H,Yang S,Zhang Y,et al.Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three-field dissection in selected patients with thoracic esophageal squamous cell carcinoma[J].J Surg Oncol,2012,105(6):548-552.
[28]Koterazawa Y,Oshikiri T,Takiguchi G,et al.Prophylactic Cervical Lymph Node Dissection in Thoracoscopic Esophagectomy for Esophageal Cancer Increases Postoperative Complications and Does Not Improve Survival[J].Ann Surg Oncol,2019,26(9):2899-2904.
[29]Miyata H,Yano M,Doki Y,et al.A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers,based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes[J].J Surg Oncol,2006,93(6):477-484.
[30]Igaki H,Tachimori Y,Kato H.Improved Survival for Patients with Upper and/or Middle Mediastinal Lymph Node Metastasis of Squamous Cell Carcinoma of the Lower Thoracic Esophagus Treated With 3-Field Dissection[J].Ann Surg,2004,239(4):483-490.
[31]Kato H,Watanabe H,Tachimori Y,et al.Evaluation of neck lymph node dissection for thoracic esophageal carcinoma[J].Ann Thorac Surg,1991,51(6):931-935.
[32]Nishihira T,Hirayama K,Mori S.A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus[J].Am J Surg,1998,175(1):47-51.
[33]Wu SG,Li FY,Zhou J,et al.Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy[J].Ann Thorac Surg,2015,99(1):284-290.
[34]Ma GW,Situ DR,Ma QL,et al.Three-field vs two-field lymph node dissection for esophageal cancer:a meta-analysis[J].World J Gastroenterol,2014,20(47):18022-18030.
[35]Nozoe T,Kakeji Y,Baba H,et al.Two-field lymphnode dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus[J].Dis Esophagus,2005,18(4):226-229.
[36]Wong J,Weber J,Almhanna K,et al.Extent oflymphadenectomy does not predict survival in patients treated with primary esophagectomy[J].J Gastrointest Surg,2013,17(9):1562-1568.
[37]Shang QX,Chen LQ,Hu WP,et al.Three-field lymph node dissection in treating the esophageal cancer[J].J Thorac Dis,2016,8(10):E1136-E1149.
[38]Yasuda T,Yano M,Miyata H,et al.Evaluation of dysphagia and diminished airway protection after three-field esophagectomy and a remedy[J].World J Surg,2013,37(2):416-423.
[39]Fang WT,Chen WH,Chen Y,et al.Selective three-field lymphadenectomy for thoracic esophageal squamous carcinoma[J].Dis Esophagus,2007,20(3):206-211.
[40]Nakamura M,Kido Y,Hosoya Y,et al.Postoperative gastrointestinal dysfunction after 2-field versus 3-field lymph node dissection in patients with esophageal cancer[J].Surg Today,2007,37(5):379-382.
[41]Li B,Zhang Y,Miao L,et al.Esophagectomy With Three-Field Versus Two-Field Lymphadenectomy for Middle and Lower Thoracic Esophageal Cancer:Long-Term Outcomes of a Randomized Clinical Trial[J].J Thorac Oncol,2021,16(2):310-317.